Dexterous Endoscopes awarded CHF 130k EPFL Ignition and Innogrant funding
Dexterous Endoscopes secured CHF 130k in EPFL Startup Launchpad funding, combining the Ignition and Innogrant programs. The support will expand the team, advance a clinically viable prototype, and enable the first cadaver trials.
Dexterous Endoscopes has received two competitive funding instruments from EPFL Startup Launchpad: an Ignition Grant of CHF 30,000 and an Innogrant of CHF 100,000.
The Ignition Grant helps early-stage EPFL spin-offs validate their concepts, while the Innogrant provides seed funding to accelerate the transition of promising research into startups with market potential.
This funding will be used to grow the team with complementary medical device expertise, advance towards a minimally clinically viable product, and conduct the first preclinical cadaver trials to validate the clinical hypotheses behind our variable stiffness endoscopes.
These steps mark important progress toward making ENT surgeries faster, less invasive, and safer for patients.
More news
Selected for Venture Kick Stage 1
Dexterous Endoscopes won Venture Kick Stage 1 and CHF 10,000 in funding. The support will help validate our business case and advance variable stiffness endoscopes toward clinical adoption.
Dexterous Endoscopes awarded Bridge PoC Extension and Innovation Booster Robotics support with pilot study at CHUV
Dexterous Endoscopes secured an additional CHF 65k Bridge PoC grant and Innovation Booster Robotics support with CHUV Hospital as implementation partner. The funding enables multiple preclinical trials and a pilot study at CHUV to de-risk usability and performance.